Description of the domestic marketing and approval status of Avatrombopag

Avatrombopag (Avatrombopag ) is an oral thrombopoietin receptor agonist, mainly used to treat thrombocytopenia associated with chronic liver disease and immune thrombocytopenia in adults. The drug promotes the proliferation and differentiation of bone marrow megakaryocytes by selectively stimulating the thrombopoietin receptor, thereby increasing platelet count and reducing the risk of bleeding. With the increasing demand for treatment of hematological diseases, the clinical application of avatrombopag has gradually attracted attention.

In China, avatrombopag has been officially launched and included in the medical insurance system, providing patients with economic convenience. At present, the common specifications on the domestic market are 20mg10 tablets and 20mg15 tablets, of which 20mg15 tablets The latest price of pan>20mg10 tablets is about more than 5,000 yuan, while the price of 20mg15 tablets is around 7,000 to 8,000 yuan. Specific medical insurance reimbursement policies and prices vary by region and hospital. Patients should consult the local hospital pharmacy before purchasing to ensure they understand the reimbursement ratio and cost.

For patients who need to purchase drugs, domestic drug channels are relatively formal, and they can usually be obtained through hospital pharmacies, which ensures the quality and safety of drugs. At the same time, during the prescription process, the doctor will combine the patient's condition, platelet level and treatment plan to formulate an individualized dose and course of treatment to ensure the effectiveness and safety of the treatment. During the medication period, patients also need to regularly monitor platelet count and liver and kidney function to detect and deal with potential adverse reactions in a timely manner.

In foreign markets, some generic versions of avatrombopag are also available, including the Lao version and the Bangladeshi version. These generic drugs are basically the same as the original drugs in terms of pharmaceutical ingredients and are relatively affordable. The latest selling price is usually around a few hundred yuan. For patients who are temporarily unable to directly purchase imported original drugs or whose prices are higher, overseas generic drugs provide a viable option, but the purchase channels must be legal and formal, and must be used under the guidance of a doctor to ensure the efficacy and safety of the drugs. At the same time, patients should pay attention to the storage conditions and transportation safety of drugs to avoid a decrease in drug efficacy or an impact on quality.

Reference materials:https://www.drugs.com/